Analysis of anti-HBs levels in healthcare workers over 10 years following booster vaccination for hepatitis B virus

In this study, we analyzed anti-HBs levels in 104 Japanese healthcare workers who received three booster HBV surface antigen (HBsAg) vaccines because 80 became anti-HBs-negative at a mean of 2.4 years after the primary vaccination and 24 did not respond to primary vaccination. Of the re-vaccinees, 9...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2003-09, Vol.21 (25-26), p.3789-3794
Main Authors: Nakao, Kazuhiko, Hamasaki, Keisuke, Wakihama, Naoko, Maeda, Mayumi, Ohtsubo, Noriko, Sagiike, Tomiko, Ichikawa, Tatsuki, Ishikawa, Hiroki, Eguchi, Katsumi, Ishii, Nobuko
Format: Article
Language:English
Subjects:
Adult
Anti-HBs
Booster vaccination
Enzymes
Female
Health care
Health Personnel
Healthcare worker
Hepatitis
Hepatitis Antibodies - blood
Hepatitis B
Hepatitis B surface antigen
Hepatitis B Surface Antigens - analysis
Hepatitis B Surface Antigens - immunology
Hepatitis B Vaccines - immunology
Hepatitis B virus
Humans
Immunization
Immunization, Secondary
Immunogenicity
Immunology
Infections
Japan
Male
Medical personnel
Middle Aged
Time Factors
Vaccines
Vaccines, Synthetic - immunology
Viruses
Workers
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c551t-f749a0bcb97b1c56c926059959eb03e907526cf53a17b635ef1f4fa3f92e60853
cites cdi_FETCH-LOGICAL-c551t-f749a0bcb97b1c56c926059959eb03e907526cf53a17b635ef1f4fa3f92e60853
container_end_page 3794
container_issue 25-26
container_start_page 3789
container_title Vaccine
container_volume 21
creator Nakao, Kazuhiko
Hamasaki, Keisuke
Wakihama, Naoko
Maeda, Mayumi
Ohtsubo, Noriko
Sagiike, Tomiko
Ichikawa, Tatsuki
Ishikawa, Hiroki
Eguchi, Katsumi
Ishii, Nobuko
description In this study, we analyzed anti-HBs levels in 104 Japanese healthcare workers who received three booster HBV surface antigen (HBsAg) vaccines because 80 became anti-HBs-negative at a mean of 2.4 years after the primary vaccination and 24 did not respond to primary vaccination. Of the re-vaccinees, 96% achieved a level of 10mIU/ml or more of anti-HBs (i.e. seroprotected), 1 month after booster vaccination. Although anti-HBs levels of re-vaccinees decreased as rapidly as those of primary immunized vaccinees, at 10 years post-booster, 64% of re-vaccinees maintained anti-HBs levels at 10mIU/ml or higher. Our results suggest that the additional three-dose protocol of booster HBsAg vaccination is beneficial in maintaining a seroprotective level of anti-HBs until new immunogenic vaccination protocols are established.
doi_str_mv 10.1016/S0264-410X(03)00313-X
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73581334</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X0300313X</els_id><sourcerecordid>1500758705</sourcerecordid><originalsourceid>FETCH-LOGICAL-c551t-f749a0bcb97b1c56c926059959eb03e907526cf53a17b635ef1f4fa3f92e60853</originalsourceid><addsrcrecordid>eNqFkk9v1DAQxS0EokvhI4AsIaFyCMzEcRKfUFsBRarEAZD2ZjneMXXJxoudpNpvj_ePQOLQnqzR_ObNyO8x9hLhHQLW779BWVdFhbA8A_EWQKAolo_YAttGFKXE9jFb_EVO2LOUbgFAClRP2QmWqiwRywVL54Ppt8knHhw3w-iLq4vEe5qpT9wP_IZMP95YE4nfhfiLYgZnihyBb8nkyoW-D3d--Mm7ENKYW7Ox1g9m9GHI3ZglNrkY84oLPvs4pefsiTN9ohfH95T9-PTx--VVcf3185fL8-vCSolj4ZpKGehsp5oOraytKmuQSklFHQhS0Miytk4Kg01XC0kOXeWMcKqkGlopTtmbg-4mht8TpVGvfbLU92agMCXdCNmiEFUGz-4FUdaAoq73mg-hkO9qG9ihr_9Db8MU83cnXaJqM1dJvI9CWSkhsqE7Sh4oG0NKkZzeRL82casR9C4Pep8HvTNbg9D7POhlnnt1VJ-6Na3-TR0DkIEPByD7TbOnqJP1NFha-Uh21KvgH1jxB9zHwzw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1549331871</pqid></control><display><type>article</type><title>Analysis of anti-HBs levels in healthcare workers over 10 years following booster vaccination for hepatitis B virus</title><source>ScienceDirect Freedom Collection</source><creator>Nakao, Kazuhiko ; Hamasaki, Keisuke ; Wakihama, Naoko ; Maeda, Mayumi ; Ohtsubo, Noriko ; Sagiike, Tomiko ; Ichikawa, Tatsuki ; Ishikawa, Hiroki ; Eguchi, Katsumi ; Ishii, Nobuko</creator><creatorcontrib>Nakao, Kazuhiko ; Hamasaki, Keisuke ; Wakihama, Naoko ; Maeda, Mayumi ; Ohtsubo, Noriko ; Sagiike, Tomiko ; Ichikawa, Tatsuki ; Ishikawa, Hiroki ; Eguchi, Katsumi ; Ishii, Nobuko</creatorcontrib><description>In this study, we analyzed anti-HBs levels in 104 Japanese healthcare workers who received three booster HBV surface antigen (HBsAg) vaccines because 80 became anti-HBs-negative at a mean of 2.4 years after the primary vaccination and 24 did not respond to primary vaccination. Of the re-vaccinees, 96% achieved a level of 10mIU/ml or more of anti-HBs (i.e. seroprotected), 1 month after booster vaccination. Although anti-HBs levels of re-vaccinees decreased as rapidly as those of primary immunized vaccinees, at 10 years post-booster, 64% of re-vaccinees maintained anti-HBs levels at 10mIU/ml or higher. Our results suggest that the additional three-dose protocol of booster HBsAg vaccination is beneficial in maintaining a seroprotective level of anti-HBs until new immunogenic vaccination protocols are established.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/S0264-410X(03)00313-X</identifier><identifier>PMID: 12922112</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adult ; Anti-HBs ; Booster vaccination ; Enzymes ; Female ; Health care ; Health Personnel ; Healthcare worker ; Hepatitis ; Hepatitis Antibodies - blood ; Hepatitis B ; Hepatitis B surface antigen ; Hepatitis B Surface Antigens - analysis ; Hepatitis B Surface Antigens - immunology ; Hepatitis B Vaccines - immunology ; Hepatitis B virus ; Humans ; Immunization ; Immunization, Secondary ; Immunogenicity ; Immunology ; Infections ; Japan ; Male ; Medical personnel ; Middle Aged ; Time Factors ; Vaccines ; Vaccines, Synthetic - immunology ; Viruses ; Workers</subject><ispartof>Vaccine, 2003-09, Vol.21 (25-26), p.3789-3794</ispartof><rights>2003 Elsevier Science Ltd</rights><rights>Copyright Elsevier Limited Sep 8, 2003</rights><rights>2003. Elsevier Science Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c551t-f749a0bcb97b1c56c926059959eb03e907526cf53a17b635ef1f4fa3f92e60853</citedby><cites>FETCH-LOGICAL-c551t-f749a0bcb97b1c56c926059959eb03e907526cf53a17b635ef1f4fa3f92e60853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12922112$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakao, Kazuhiko</creatorcontrib><creatorcontrib>Hamasaki, Keisuke</creatorcontrib><creatorcontrib>Wakihama, Naoko</creatorcontrib><creatorcontrib>Maeda, Mayumi</creatorcontrib><creatorcontrib>Ohtsubo, Noriko</creatorcontrib><creatorcontrib>Sagiike, Tomiko</creatorcontrib><creatorcontrib>Ichikawa, Tatsuki</creatorcontrib><creatorcontrib>Ishikawa, Hiroki</creatorcontrib><creatorcontrib>Eguchi, Katsumi</creatorcontrib><creatorcontrib>Ishii, Nobuko</creatorcontrib><title>Analysis of anti-HBs levels in healthcare workers over 10 years following booster vaccination for hepatitis B virus</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>In this study, we analyzed anti-HBs levels in 104 Japanese healthcare workers who received three booster HBV surface antigen (HBsAg) vaccines because 80 became anti-HBs-negative at a mean of 2.4 years after the primary vaccination and 24 did not respond to primary vaccination. Of the re-vaccinees, 96% achieved a level of 10mIU/ml or more of anti-HBs (i.e. seroprotected), 1 month after booster vaccination. Although anti-HBs levels of re-vaccinees decreased as rapidly as those of primary immunized vaccinees, at 10 years post-booster, 64% of re-vaccinees maintained anti-HBs levels at 10mIU/ml or higher. Our results suggest that the additional three-dose protocol of booster HBsAg vaccination is beneficial in maintaining a seroprotective level of anti-HBs until new immunogenic vaccination protocols are established.</description><subject>Adult</subject><subject>Anti-HBs</subject><subject>Booster vaccination</subject><subject>Enzymes</subject><subject>Female</subject><subject>Health care</subject><subject>Health Personnel</subject><subject>Healthcare worker</subject><subject>Hepatitis</subject><subject>Hepatitis Antibodies - blood</subject><subject>Hepatitis B</subject><subject>Hepatitis B surface antigen</subject><subject>Hepatitis B Surface Antigens - analysis</subject><subject>Hepatitis B Surface Antigens - immunology</subject><subject>Hepatitis B Vaccines - immunology</subject><subject>Hepatitis B virus</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization, Secondary</subject><subject>Immunogenicity</subject><subject>Immunology</subject><subject>Infections</subject><subject>Japan</subject><subject>Male</subject><subject>Medical personnel</subject><subject>Middle Aged</subject><subject>Time Factors</subject><subject>Vaccines</subject><subject>Vaccines, Synthetic - immunology</subject><subject>Viruses</subject><subject>Workers</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkk9v1DAQxS0EokvhI4AsIaFyCMzEcRKfUFsBRarEAZD2ZjneMXXJxoudpNpvj_ePQOLQnqzR_ObNyO8x9hLhHQLW779BWVdFhbA8A_EWQKAolo_YAttGFKXE9jFb_EVO2LOUbgFAClRP2QmWqiwRywVL54Ppt8knHhw3w-iLq4vEe5qpT9wP_IZMP95YE4nfhfiLYgZnihyBb8nkyoW-D3d--Mm7ENKYW7Ox1g9m9GHI3ZglNrkY84oLPvs4pefsiTN9ohfH95T9-PTx--VVcf3185fL8-vCSolj4ZpKGehsp5oOraytKmuQSklFHQhS0Miytk4Kg01XC0kOXeWMcKqkGlopTtmbg-4mht8TpVGvfbLU92agMCXdCNmiEFUGz-4FUdaAoq73mg-hkO9qG9ihr_9Db8MU83cnXaJqM1dJvI9CWSkhsqE7Sh4oG0NKkZzeRL82casR9C4Pep8HvTNbg9D7POhlnnt1VJ-6Na3-TR0DkIEPByD7TbOnqJP1NFha-Uh21KvgH1jxB9zHwzw</recordid><startdate>20030908</startdate><enddate>20030908</enddate><creator>Nakao, Kazuhiko</creator><creator>Hamasaki, Keisuke</creator><creator>Wakihama, Naoko</creator><creator>Maeda, Mayumi</creator><creator>Ohtsubo, Noriko</creator><creator>Sagiike, Tomiko</creator><creator>Ichikawa, Tatsuki</creator><creator>Ishikawa, Hiroki</creator><creator>Eguchi, Katsumi</creator><creator>Ishii, Nobuko</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7U2</scope><scope>7X8</scope></search><sort><creationdate>20030908</creationdate><title>Analysis of anti-HBs levels in healthcare workers over 10 years following booster vaccination for hepatitis B virus</title><author>Nakao, Kazuhiko ; Hamasaki, Keisuke ; Wakihama, Naoko ; Maeda, Mayumi ; Ohtsubo, Noriko ; Sagiike, Tomiko ; Ichikawa, Tatsuki ; Ishikawa, Hiroki ; Eguchi, Katsumi ; Ishii, Nobuko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c551t-f749a0bcb97b1c56c926059959eb03e907526cf53a17b635ef1f4fa3f92e60853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Anti-HBs</topic><topic>Booster vaccination</topic><topic>Enzymes</topic><topic>Female</topic><topic>Health care</topic><topic>Health Personnel</topic><topic>Healthcare worker</topic><topic>Hepatitis</topic><topic>Hepatitis Antibodies - blood</topic><topic>Hepatitis B</topic><topic>Hepatitis B surface antigen</topic><topic>Hepatitis B Surface Antigens - analysis</topic><topic>Hepatitis B Surface Antigens - immunology</topic><topic>Hepatitis B Vaccines - immunology</topic><topic>Hepatitis B virus</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization, Secondary</topic><topic>Immunogenicity</topic><topic>Immunology</topic><topic>Infections</topic><topic>Japan</topic><topic>Male</topic><topic>Medical personnel</topic><topic>Middle Aged</topic><topic>Time Factors</topic><topic>Vaccines</topic><topic>Vaccines, Synthetic - immunology</topic><topic>Viruses</topic><topic>Workers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakao, Kazuhiko</creatorcontrib><creatorcontrib>Hamasaki, Keisuke</creatorcontrib><creatorcontrib>Wakihama, Naoko</creatorcontrib><creatorcontrib>Maeda, Mayumi</creatorcontrib><creatorcontrib>Ohtsubo, Noriko</creatorcontrib><creatorcontrib>Sagiike, Tomiko</creatorcontrib><creatorcontrib>Ichikawa, Tatsuki</creatorcontrib><creatorcontrib>Ishikawa, Hiroki</creatorcontrib><creatorcontrib>Eguchi, Katsumi</creatorcontrib><creatorcontrib>Ishii, Nobuko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Safety Science and Risk</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakao, Kazuhiko</au><au>Hamasaki, Keisuke</au><au>Wakihama, Naoko</au><au>Maeda, Mayumi</au><au>Ohtsubo, Noriko</au><au>Sagiike, Tomiko</au><au>Ichikawa, Tatsuki</au><au>Ishikawa, Hiroki</au><au>Eguchi, Katsumi</au><au>Ishii, Nobuko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of anti-HBs levels in healthcare workers over 10 years following booster vaccination for hepatitis B virus</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2003-09-08</date><risdate>2003</risdate><volume>21</volume><issue>25-26</issue><spage>3789</spage><epage>3794</epage><pages>3789-3794</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>In this study, we analyzed anti-HBs levels in 104 Japanese healthcare workers who received three booster HBV surface antigen (HBsAg) vaccines because 80 became anti-HBs-negative at a mean of 2.4 years after the primary vaccination and 24 did not respond to primary vaccination. Of the re-vaccinees, 96% achieved a level of 10mIU/ml or more of anti-HBs (i.e. seroprotected), 1 month after booster vaccination. Although anti-HBs levels of re-vaccinees decreased as rapidly as those of primary immunized vaccinees, at 10 years post-booster, 64% of re-vaccinees maintained anti-HBs levels at 10mIU/ml or higher. Our results suggest that the additional three-dose protocol of booster HBsAg vaccination is beneficial in maintaining a seroprotective level of anti-HBs until new immunogenic vaccination protocols are established.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>12922112</pmid><doi>10.1016/S0264-410X(03)00313-X</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2003-09, Vol.21 (25-26), p.3789-3794
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_miscellaneous_73581334
source ScienceDirect Freedom Collection
subjects Adult
Anti-HBs
Booster vaccination
Enzymes
Female
Health care
Health Personnel
Healthcare worker
Hepatitis
Hepatitis Antibodies - blood
Hepatitis B
Hepatitis B surface antigen
Hepatitis B Surface Antigens - analysis
Hepatitis B Surface Antigens - immunology
Hepatitis B Vaccines - immunology
Hepatitis B virus
Humans
Immunization
Immunization, Secondary
Immunogenicity
Immunology
Infections
Japan
Male
Medical personnel
Middle Aged
Time Factors
Vaccines
Vaccines, Synthetic - immunology
Viruses
Workers
title Analysis of anti-HBs levels in healthcare workers over 10 years following booster vaccination for hepatitis B virus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T13%3A13%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20anti-HBs%20levels%20in%20healthcare%20workers%20over%2010%20years%20following%20booster%20vaccination%20for%20hepatitis%20B%20virus&rft.jtitle=Vaccine&rft.au=Nakao,%20Kazuhiko&rft.date=2003-09-08&rft.volume=21&rft.issue=25-26&rft.spage=3789&rft.epage=3794&rft.pages=3789-3794&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/S0264-410X(03)00313-X&rft_dat=%3Cproquest_cross%3E1500758705%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c551t-f749a0bcb97b1c56c926059959eb03e907526cf53a17b635ef1f4fa3f92e60853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1549331871&rft_id=info:pmid/12922112&rfr_iscdi=true